Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

ClinicalTrials.gov ID: NCT04044690

Public ClinicalTrials.gov record NCT04044690. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra®) in Adults With Dermatomyositis (DM) - The RECLAIIM Study

Study identification

NCT ID
NCT04044690
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CSL Behring
Industry
Enrollment
134 participants

Conditions and interventions

Interventions

  • human immunoglobulin G Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 20, 2019
Primary completion
Dec 1, 2024
Completion
Dec 1, 2024
Last update posted
Dec 8, 2025

2019 – 2024

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
8401117 - Arizona Arthritis & Rheumatology Research Glendale Arizona 85306
8401199 - Neuromuscular Research Center Phoenix Arizona 85028
8401129 - UCLA - Rheumatology Los Angeles Los Angeles California 90095
8401473 - RecioMed Clinical Research Network, Inc. Boynton Beach Florida 33472
8401160 - Center For Rheumatology Fort Lauderdale Florida 33334
8401132 - Omega Research Maitland Orlando Florida 32810
8401107 - Morsani Center for Advanced Health Care (CAHC) Tampa Florida 33616
8401152 - The University of Kansas Medical Center Fairway Kansas 66205
8401476 - DS Research Louisville Kentucky 40241
8401487 - Ohio State University Columbus Ohio 43210
8401486 - Oregon Health and Science University Portland Oregon 97239
8401210 - University of Pennsylvania Philadelphia Pennsylvania 19104
8401151 - Biomedical Science Tower Pittsburgh Pennsylvania 15261
8401474 - West Tennessee Research Institute, LLC Jackson Tennessee 38305
8401115 - The University of Texas Medical School at Houston Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04044690, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04044690 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →